Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
2.150
+0.040 (1.90%)
At close: Feb 10, 2026, 4:00 PM EST
2.258
+0.108 (5.02%)
After-hours: Feb 10, 2026, 7:54 PM EST
Enveric Biosciences Employees
As of December 31, 2024, Enveric Biosciences had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees decreased by 1 or -14.29% compared to the previous year.
Employees
6
Change (1Y)
-1
Growth (1Y)
-14.29%
Revenue / Employee
n/a
Profits / Employee
-$1,874,319
Market Cap
2.99M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 6 | -1 | -14.29% | 5 | 1 |
| Dec 31, 2023 | 7 | -19 | -73.08% | 7 | 0 |
| Dec 31, 2022 | 26 | 2 | 8.33% | 25 | 1 |
| Dec 31, 2021 | 24 | 21 | 700.00% | 23 | 1 |
| Dec 31, 2020 | 3 | - | - | 2 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Jaguar Health | 49 |
| Lyra Therapeutics | 30 |
| Galmed Pharmaceuticals | 6 |
| Ernexa Therapeutics | 6 |
| Adial Pharmaceuticals | 5 |
| Oragenics | 5 |
| Artelo Biosciences | 5 |
| GRI Bio | 4 |
ENVB News
- 12 days ago - Enveric Biosciences Expands Collaboration with TOTEC Pharma through Trademark License and Option - Business Wire
- 13 days ago - Enveric Biosciences Announces Closing of $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 13 days ago - Enveric Biosciences Announces $1.5 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules - Business Wire
- 6 weeks ago - Enveric Biosciences Announces Patent Issuance - Business Wire
- 2 months ago - Enveric Biosciences Announces Closing of Exercise of Warrants for $3.1 Million Gross Proceeds - Business Wire
- 2 months ago - Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds - Business Wire
- 2 months ago - Enveric Biosciences Receives Notice of Allowance for EVM301 Series of Drug Candidates - Business Wire
- 2 months ago - Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 9th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2026” - Business Wire